224 related articles for article (PubMed ID: 32531030)
1. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
Gupta D; Vijgen J; Potter T; Scherr D; Van Herendael H; Knecht S; Kobza R; Berte B; Sandgaard N; Albenque JP; Széplaki G; Stevenhagen Y; Taghji P; Wright M; Duytschaever M
Heart; 2021 Aug; 107(16):1296-1302. PubMed ID: 33952593
[TBL] [Abstract][Full Text] [Related]
3. Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.
Samuel M; Khairy P; Champagne J; Deyell MW; Macle L; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Tardif JC; Andrade JG
JAMA Cardiol; 2021 Nov; 6(11):1324-1328. PubMed ID: 34406350
[TBL] [Abstract][Full Text] [Related]
4. Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
Boersma L; Koźluk E; Maglia G; de Sousa J; Grebe O; Eckardt L; Hokanson RB; Hemingway LA; Ostern E; Park HS; Rovaris G; Arribas F; Scharf C; Csanádi Z; Arenal Á; Laurenzi F; Klaver M; Goette A
Europace; 2020 Jun; 22(6):888-896. PubMed ID: 32219388
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
Zeitler EP; Li Y; Silverstein AP; Russo AM; Poole JE; Daniels MR; Al-Khalidi HR; Lee KL; Bahnson TD; Anstrom KJ; Packer DL; Mark DB;
J Am Heart Assoc; 2023 Feb; 12(3):e027871. PubMed ID: 36688367
[TBL] [Abstract][Full Text] [Related]
6. Positive Clinical Benefit on Patient Care, Quality of Life, and Symptoms After Contact Force-Guided Radiofrequency Ablation in Persistent Atrial Fibrillation: Analyses From the PRECEPT Prospective Multicenter Study.
Natale A; Calkins H; Osorio J; Pollak SJ; Melby D; Marchlinski FE; Athill CA; Delaughter C; Patel AM; Gentlesk PJ; DeVille B; Macle L; Ellenbogen KA; Dukkipati SR; Reddy VY; Mansour M;
Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008867. PubMed ID: 33290093
[TBL] [Abstract][Full Text] [Related]
7. Association Between Quality of Life and Procedural Outcome After Catheter Ablation for Atrial Fibrillation: A Secondary Analysis of a Randomized Clinical Trial.
Terricabras M; Mantovan R; Jiang CY; Betts TR; Chen J; Deisenhofer I; Macle L; Morillo CA; Haverkamp W; Weerasooriya R; Albenque JP; Nardi S; Menardi E; Novak P; Sanders P; Verma A;
JAMA Netw Open; 2020 Dec; 3(12):e2025473. PubMed ID: 33275151
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation.
Looi KL; Gajendragadkar P; Taha T; Elsik M; Scully E; Heck P; Fynn S; Virdee M; Begley D
J Interv Card Electrophysiol; 2013 Jan; 36(1):61-9; discussion 69. PubMed ID: 23097007
[TBL] [Abstract][Full Text] [Related]
9. Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA.
Monahan KH; Bunch TJ; Mark DB; Poole JE; Bahnson TD; Al-Khalidi HR; Silverstein AP; Daniels MR; Lee KL; Packer DL;
Europace; 2022 Oct; 24(9):1430-1440. PubMed ID: 35640922
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study.
Shiraishi Y; Kohsaka S; Ikemura N; Kimura T; Katsumata Y; Tanimoto K; Suzuki M; Ueda I; Fukuda K; Takatsuki S
Europace; 2023 Feb; 25(1):83-91. PubMed ID: 35851807
[TBL] [Abstract][Full Text] [Related]
11. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial.
Mantovan R; Macle L; De Martino G; Chen J; Morillo CA; Novak P; Calzolari V; Khaykin Y; Guerra PG; Nair G; Torrecilla EG; Verma A
Can J Cardiol; 2013 Oct; 29(10):1211-7. PubMed ID: 23988341
[TBL] [Abstract][Full Text] [Related]
12. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Mark DB; Anstrom KJ; Sheng S; Piccini JP; Baloch KN; Monahan KH; Daniels MR; Bahnson TD; Poole JE; Rosenberg Y; Lee KL; Packer DL;
JAMA; 2019 Apr; 321(13):1275-1285. PubMed ID: 30874716
[TBL] [Abstract][Full Text] [Related]
13. Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry.
De Potter T; Van Herendael H; Balasubramaniam R; Wright M; Agarwal SC; Sanders P; Khaykin Y; Latcu DG; Maury P; Pani A; Hayes J; Kalman J; Nery P; Duncan E
Europace; 2018 Nov; 20(FI_3):f410-f418. PubMed ID: 29315382
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in symptoms and functional status in patients with atrial fibrillation undergoing catheter ablation.
Bazemore TC; Bolger LE; Sears SF; Sadaf MI; Gehi AK
Pacing Clin Electrophysiol; 2019 Feb; 42(2):224-229. PubMed ID: 30548873
[TBL] [Abstract][Full Text] [Related]
15. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
Nielsen JC; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Pehrson SM; Englund A; Hartikainen J; Mortensen LS; Hansen PS;
Heart; 2017 Mar; 103(5):368-376. PubMed ID: 27566295
[TBL] [Abstract][Full Text] [Related]
17. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.
Packer DL; Piccini JP; Monahan KH; Al-Khalidi HR; Silverstein AP; Noseworthy PA; Poole JE; Bahnson TD; Lee KL; Mark DB;
Circulation; 2021 Apr; 143(14):1377-1390. PubMed ID: 33554614
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
[TBL] [Abstract][Full Text] [Related]
19. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
[TBL] [Abstract][Full Text] [Related]
20. Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation.
Osmancik P; Budera P; Talavera D; Herman D; Vesela J; Prochazkova R; Rizov V; Kacer P
J Interv Card Electrophysiol; 2020 Apr; 57(3):435-442. PubMed ID: 31001766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
